In this series, Dr. Jason Hafron discusses the latest advancements in testing and treating prostate cancer from the American Urological Association’s 2024 Annual Meeting and their clinical relevance to practice.
Real-World Sequencing and Survival in Locally Advanced Prostate Cancer
Real-World Sequencing and Survival in Locally Advanced Prostate Cancer
Updates from Apa-RP: Apalutamide and ADT in High-Risk Localized Prostate Cancer
Updates from Apa-RP: Apalutamide and ADT in High-Risk Localized Prostate Cancer
Evolving Trends in Germline Genetic Testing for Prostate Cancer
Evolving Trends in Germline Genetic Testing for Prostate Cancer
